Franklin Resources Inc Tempest Therapeutics, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.62 - $2.76 $542 - $924	335 Added 3.05%	11,308 $20,000
Q2 2022 Aug 11, 2022	SELL	$2.08 - $4.15 $10,040 - $20,032	-4,827 Reduced 30.55%	10,973 $23,000
Q1 2022 May 13, 2022	BUY	$2.27 - $5.45 $1,271 - $3,052	560 Added 3.67%	15,800 $54,000
Q3 2021 Nov 12, 2021	BUY	$10.49 - $24.19 $159,867 - $368,655	15,240 New	15,240 $221,000

2.46M

44.9K

109K

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $9.59M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.